ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: herpes zoster

Biosimilar for Infliximab Launched in Europe

Michele B. Kaufman, PharmD, BCGP  |  April 1, 2015

Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiosimilarsDrugsFDAinfliximabKaufmanrheumatologySafety

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support

Kathy Holliman  |  January 1, 2015

Patient Centered Outcomes Research Institute executives review PCORI’s funding, research focus and the importance of including patients as partners

Filed under:Meeting ReportsResearch Rheum Tagged with:2014 ACR/ARHP Annual MeetingFundingHollimanoutcomepatient carePCORIResearchrheumatology

The Science of Chronic Itch

Shivani V. Tripathi, MD, & Brian S. Kim, MD, MTR  |  December 1, 2014

Inside the pathophysiology, clinical presentations of chronic pruritus

Filed under:ConditionsEducation & TrainingMyositisProfessional TopicsResearch Rheum Tagged with:chronic pruritusitchKimmyositispathophysiologypatient careResearchrheumatology

Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals

Michele B. Kaufman, PharmD, BCGP  |  October 1, 2014

Plus, rheumatology drug news, safety updates

Filed under:ConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:drugFDAInjectionKaufmanMethotrexateResearchRheumatoid arthritisrheumatologistSafetyTofacitinib

Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis

Gretchen Henkel  |  July 1, 2014

Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:baricitinibBiologicsdrugJAK inhibitorsMethotrexateradiographResearchRheumatoid arthritisTofacitinib

7 Things Ophthalmologists Want Rheumatologists to Know

Vanessa Caceres  |  May 1, 2014

Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes

Filed under:Axial SpondyloarthritisCareer DevelopmentConditionsEducation & TrainingProfessional TopicsRheumatoid ArthritisSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:Ankylosing Spondylitisgranulomatosis with polyangiitisLupusmultidisciplinary careocular diseaseOphthalmologistpatient careReactive arthritisRheumatic DiseaseRheumatoid arthritisrheumatologistSjogren'sVasculitis

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

Deborah L. Parks, MD  |  June 1, 2013

Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:JAK inhibitorsRARheumatic DiseaseRheumatoid arthritisTofacitinibTreatment

ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

Staff  |  May 1, 2013

Toxicity and appropriate targeting are challenges for small molecule researchers

Filed under:Drug UpdatesMeeting ReportsResearch Rheum Tagged with:AC&RACR Winter Rheumatology Symposiumkinase inhibitorResearch

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:ApprovalsopioidPipelineSafety

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences